John Mann

5.9k total citations · 1 hit paper
163 papers, 4.4k citations indexed

About

John Mann is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, John Mann has authored 163 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Organic Chemistry, 73 papers in Molecular Biology and 18 papers in Pharmacology. Recurrent topics in John Mann's work include Synthetic Organic Chemistry Methods (20 papers), Asymmetric Synthesis and Catalysis (19 papers) and Plant biochemistry and biosynthesis (17 papers). John Mann is often cited by papers focused on Synthetic Organic Chemistry Methods (20 papers), Asymmetric Synthesis and Catalysis (19 papers) and Plant biochemistry and biosynthesis (17 papers). John Mann collaborates with scholars based in United Kingdom, United States and Brazil. John Mann's co-authors include Stephen Neidle, Alessandra Cirla, Anne Baron, Yaw Opoku‐Boahen, Luiz C. A. Barbosa, Eric Johansson, Lloyd R. Kèlland, Alexander C. Weymouth‐Wilson, D. V. Banthorpe and Gary N. Parkinson and has published in prestigious journals such as Nature, Chemical Society Reviews and Nucleic Acids Research.

In The Last Decade

John Mann

161 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Natural products in cancer chemotherapy: past, present and future

2002 565 citations John Mann profile →

Peers

Countries citing papers authored by John Mann

Since Specialization

Citations

This map shows the geographic impact of John Mann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Mann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Mann more than expected).

Fields of papers citing papers by John Mann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Mann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Mann. The network helps show where John Mann may publish in the future.

Co-authorship network of co-authors of John Mann

This figure shows the co-authorship network connecting the top 25 collaborators of John Mann. A scholar is included among the top collaborators of John Mann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Mann. John Mann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Symmetric bis-benzimidazoles as DNA minor groove-binding agents with anti-tumour and antibacterial activity, and the evolution of the drug ridinilazole for the treatment of Clostridium difficile infections 2022 ·Bioorganic & Medicinal Chemistry ·Anne Baron, (unknown), John Mann	19
2	De Novo variants in the KMT2A (MLL) gene causing atypical Wiedemann-Steiner syndrome in two unrelated individuals identified by clinical exome sequencing 2014 ·BMC Medical Genetics ·Samuel P. Strom, Reymundo Lozano, Hane Lee, Naghmeh Dorrani, John Mann, (unknown), Nicole Mans, Joshua L. Deignan, Éric Vilain, Stanley F. Nelson, Wayne W. Grody, Fabiola Quintero‐Rivera	44
3	Antibacterial activity of head-to-head bis-benzimidazoles 2013 ·International Journal of Antimicrobial Agents ·(unknown), John Mann, Stephen Neidle, Timothy D. McHugh, Peter W. Taylor	32
4	A concise and convergent (formal) total synthesis of huperzine A 2006 ·Organic & Biomolecular Chemistry ·(unknown), (unknown), John Mann	30
5	New mustard-linked 2-aryl-bis-benzimidazoles with anti-proliferative activity 2006 ·Organic & Biomolecular Chemistry ·(unknown), Anne Baron, John Mann, Hendrik Van den Berg, Mekala Gunaratnam, Stephen Neidle	39
6	Synthesis and evaluation of analogues of 10H-indolo[3,2-b]quinoline as G-quadruplex stabilising ligands and potential inhibitors of the enzyme telomerase 2004 ·Organic & Biomolecular Chemistry ·(unknown), Christoph Schultes, Pascale Hazel, John Mann, Stephen Neidle	91
7	Mechanistic and anti-proliferative studies of two novel, biologically active bis-benzimidazoles 2003 ·European Journal of Cancer ·Angela Seaton, Catherine Higgins, John Mann, Anne Baron, Christian Bailly, Stephen Neidle, Henk van den Berg	39
8	A convergent approach to huperzine A and analoguesElectronic supplementary information (ESI) available: further experimental details. See http://www.rsc.org/suppdata/ob/b3/b305869g/ 2003 ·Organic & Biomolecular Chemistry ·(unknown), (unknown), John Mann, Jonathan Bentley	18
9	Natural products as immunosuppressive agents 2001 ·Natural Product Reports ·John Mann	144
10	A novel inhibitor of human telomerase derived from 10H-indolo[3,2-b]quinoline 2000 ·Bioorganic & Medicinal Chemistry Letters ·Vittorio Caprio, (unknown), Yaw Opoku‐Boahen, John Mann, Sharon Gowan, (unknown), Martin A. Read, Stephen Neidle	97
11	Identification of New Heterocyclic Nitrogen Compounds from Glucose-Lysine and Xylose-Lysine Maillard Model Systems 2000 ·Journal of Agricultural and Food Chemistry ·Richard G. Bailey, Jennifer M. Ames, John Mann	8
12	Analysis of Furanone, Pyranone, and New Heterocyclic Colored Compounds from Sugar−Glycine Model Maillard Systems 1999 ·Journal of Agricultural and Food Chemistry ·Jennifer M. Ames, Richard G. Bailey, John Mann	23
13	Structure–Activity Relationships for Triphenylethylene Antiestrogens on Hepatic Phase-I and Phase-II Enzyme Expression 1998 ·Biochemical Pharmacology ·Emile F. Nuwaysir, Yvonne P. Dragan, R. MCCAGUE, Patrice Martin, John Mann, V. Craig Jordan, Henry C. Pitot	7
14	Induction of hepatic aneuploidy in vivo by tamoxifen, toremifene and idoxifene in female Sprague-Dawley rats 1996 ·Carcinogenesis ·Linda M. Sargent, Yvonne P. Dragan, C A Sattler, (unknown), Gerald L. Sattler, Patrice Martin, Angela Cisneros, John Mann, (unknown), V. Craig Jordan, Henry C. Pitot	28
15	Novel reactions of 2-carbomethoxymethyl-2-thiophenyl-8-oxabicyelo[3.2.1]octan-3-one 1995 ·Tetrahedron ·M.M.M. Rubinger, John Mann, Michael G. B. Drew	5
16	Drugs from natural products 1993 ·Trends in Pharmacological Sciences ·John Mann	3
17	Synthesis of 2′,3′-dideoxy-2′,3′-α-methanocytidine 1990 ·Carbohydrate Research ·(unknown), (unknown), John Mann, (unknown)	31
18	A practical synthesis of (S)-5-hydroxymethylfuran-2(5H)-one from 1,2:5,6-di-O-isopropylidene-D-mannose 1987 ·Journal of Chemical Research Synopses ·John Mann, (unknown), (unknown)	4
19	Synthesis and evaluation of analogues of 4-androstene-3,17-dione as aromatase inhibitors 1987 ·Steroids ·Martin Rowlands, A. B. Foster, John Mann, (unknown), (unknown), R. Charles Coombes	14
20	Rearrangements of aryl-8-oxabicyclo[3.2.1]octenones: synthesis of novel biaryls and 1-aryl-3-furylpropanones 1985 ·Journal of the Chemical Society Chemical Communications ·John Mann, (unknown), (unknown)	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact